Abstract | OBJECTIVE: Male rats transgenic for HLA-B27 and human β(2) -microglobulin (hβ(2) m) spontaneously develop epididymoorchitis (EO) preceding the development of spondylarthritis (SpA). In the specific B27/hβ(2) m-transgenic rat cross-strain (21-3 × 382-2)F(1) , only the males develop SpA, and neither sex develops gut inflammation. This study was undertaken to determine whether EO and SpA in male (21-3 × 382-2)F(1) rats are causally related. In addition, the primary characteristics of EO in this rat arthritis model were assessed. METHODS: Male B27/hβ(2) m-transgenic (21-3 × 382-2)F(1) rats underwent bilateral, unilateral, or sham epididymoorchiectomy between ages 36 and 125 days. The castrated rats were given testosterone replacement. Alternatively, the 21-3 and 283-2 transgene loci were crossed with a transgene inducing aspermatogenesis. Rats were observed for the development of EO, arthritis, and spondylitis. RESULTS: In unmanipulated transgenic rats, inflammation was first evident in the ductuli efferentes (DE; ducts linking the rete testis to epididymis) as early as age 30 days. The inflammation was initially neutrophilic, and later became granulomatous. Antisperm and anti-testis cell antibodies appeared in the rat serum after age 70 days. Cells infiltrating the testes were predominantly CD4+ T cells and CD68+ or CD163+ macrophages. Quantitative polymerase chain reaction of the DE, epididymis, and testis showed elevations in the levels of interferon-γ, interleukin-10 (IL-10), and IL-17A. In addition, levels of IL-12A, IL-22, IL-23A, and IL-23 receptor were found to be elevated in the DE. Remarkably, castration of the rats before age 91 days completely prevented the subsequent onset of arthritis and spondylitis, as did transgene-induced azospermia. CONCLUSION: Autoimmune EO develops spontaneously in HLA-B27/hβ(2) m-transgenic (21-3 × 283-2)F(1) rats at age 30 days, the age when antigen-positive meiotic germ cells first exit the testis. Persistent testicular inflammation and/or antigenic stimulation are essential prerequisites for the subsequent development of SpA. Thus, dysregulated innate immunity at immune-privileged sites may be an essential mechanism triggering the onset of SpA.
|
Authors | Joel D Taurog, Claudia Rival, Leonie M van Duivenvoorde, Nimman Satumtira, Martha L Dorris, Margaret Sun, John M Shelton, James A Richardson, F Kent Hamra, Robert E Hammer, Kenneth S K Tung |
Journal | Arthritis and rheumatism
(Arthritis Rheum)
Vol. 64
Issue 8
Pg. 2518-28
(Aug 2012)
ISSN: 1529-0131 [Electronic] United States |
PMID | 22488218
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 by the American College of Rheumatology. |
Chemical References |
- Cytokines
- DAZL protein, rat
- HLA-B27 Antigen
- RNA-Binding Proteins
|
Topics |
- Animals
- Autoimmune Diseases
(complications, immunology)
- Cytokines
(metabolism)
- Disease Models, Animal
- Epididymis
(metabolism, surgery)
- Epididymitis
(complications, immunology)
- Female
- HLA-B27 Antigen
(genetics)
- Immunity, Innate
(immunology)
- Male
- Orchitis
(complications, immunology)
- Phenotype
- RNA-Binding Proteins
(genetics)
- Rats
- Rats, Sprague-Dawley
- Rats, Transgenic
- Sex Characteristics
- Spondylarthritis
(etiology, genetics, immunology)
- Testis
(metabolism, surgery)
- Transgenes
(genetics)
|